Press release
United States Gabapentin Market 2024-2031: Rising Neuropathic Pain, Epilepsy, and Chronic Disorder Treatments Driving Growth | Zydus Pharmaceuticals, Inc., Glenmark Pharmaceuticals Limited, Sun Pharmaceutical Industries Ltd
Gabapentin Market
The Gabapentin Market is centered around an anticonvulsant drug used to treat epilepsy, neuropathic pain, and restless leg syndrome. Rising prevalence of chronic pain conditions drives demand globally. Generic availability and favorable reimbursement policies boost market accessibility. Research into extended-release and combination formulations enhances clinical outcomes. However, regulatory scrutiny over misuse influences distribution strategies. The market maintains steady growth supported by expanding neurological disorder incidence.
📌 Download Sample Report to Identify Emerging Deals & Opportunities in the Gabapentin Market Landscape:- https://datamintelligence.com/download-sample/gabapentin-market?rk
☛ Gabapentin Market Recent Developments 2025:
United States:
✅ In July 2025, Pfizer expanded its gabapentin production to meet increasing demand for neuropathic pain and seizure management.
✅ In June 2025, Mylan Pharmaceuticals launched an extended-release gabapentin formulation to improve patient compliance.
Japan:
✅ In August 2025, Sumitomo Pharma introduced generic gabapentin formulations optimized for neuropathic pain treatment.
✅ In May 2025, Taisho Pharmaceutical expanded research on combination therapies incorporating gabapentin for chronic pain management.
☛ Gabapentin Market Trends:
Gabapentin is used for neuropathic pain, epilepsy, and anxiety disorders. Growth is driven by rising neurological disorder prevalence and increasing off-label use.
Trends include extended-release formulations and combination therapies. North America and Europe dominate due to high prescription rates, while Asia-Pacific grows with increasing awareness. Regulatory scrutiny and side-effect management are challenges.
☛ Gabapentin Market Competitve Landscape:
Zydus Pharmaceuticals, Inc., Glenmark Pharmaceuticals Limited, Sun Pharmaceutical Industries Ltd., Ascend Laboratories, LLC, Apotex Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma USA, Amneal Pharmaceuticals LLC, Pfizer Inc., and Cipla Inc.
Research Methodology
We follow a hybrid research approach, combining qualitative insights with rigorous quantitative analysis to deliver reliable and comprehensive market intelligence. Our process begins with extensive secondary research, drawing on trusted industry reports, proprietary databases, and credible market sources. This is then reinforced through targeted primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.
📌 Request a Customized Market Report - Tailored insights to match your business goals: https://datamintelligence.com/customize/gabapentin-market
☛ Segment Covered in the Gabapentin Market:
By Type: eneric, Branded
By Dosage Form: Tablet, Capsule, Solution
By Application: Neuropathic Pain, Epilepsy, Restless Leg Syndrome, Anxiety, Others
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
☛ This Report Includes:
✔ Comprehensive go-to-market strategies with actionable insights.
✔ Unbiased evaluation of overall market performance.
✔ Deep-dive analysis into development trends, competitive landscape, supply-demand dynamics, YoY growth, benchmarking, vendor mapping, market access, and overall progress.
✔ Tailored regional and country-level reports with detailed localized analysis available on request.
✔ Identification of niche segments and high-growth regions presenting strong opportunities.
✔ Accurate regional forecasts using both top-down and bottom-up approaches.
📌 Get Corporate Access to Live Gabapentin Industry Intelligence Database: https://www.datamintelligence.com/buy-now-page?report=gabapentin-market
☛ Regional Analysis for Gabapentin Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
☛ FAQ's
Q: Which regions are dominating the Gabapentin Market and which are fastest-growing?
A: North America dominating the Gabapentin Market.
📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription
☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Gabapentin Market 2024-2031: Rising Neuropathic Pain, Epilepsy, and Chronic Disorder Treatments Driving Growth | Zydus Pharmaceuticals, Inc., Glenmark Pharmaceuticals Limited, Sun Pharmaceutical Industries Ltd here
News-ID: 4209882 • Views: …
More Releases from DataM Intelligence 4market Research LLP
Precious Metal Market 2024-2031: Gold, Silver, Platinum, and Palladium Demand Dr …
Global Precious Metal Market reached US$ 209.4 billion in 2023 and is expected to reach US$ 300.3 million by 2031, growing with a CAGR of 5.2% during the forecast period 2024-2031.
The Precious Metal Market includes gold, silver, platinum, and palladium-valued for investment, industrial, and ornamental uses. Demand fluctuates with economic cycles, inflation, and geopolitical tensions. Industrial applications in electronics, automotive, and renewable energy drive steady growth. Sustainability trends encourage recycling…
Fruit-Based Probiotic Drinks Market Sees Robust Growth from Flavored, Multi-Frui …
Global Fruit-Based Probiotic Drinks Market reached US$ 520.1 million in 2023 and is expected to reach US$ 1020.3 million by 2031, growing with a CAGR of 10.1% during the forecast period 2024-2031.
The Fruit-Based Probiotic Drinks Market combines the benefits of probiotics with the appeal of fruit-based beverages. It is driven by rising consumer focus on digestive health and immunity. Manufacturers are introducing low-sugar, dairy-free probiotic formulations using natural fermentation. The…
Rhodiola Extract Market Sees Robust Demand for Stress-Relief and Mental Performa …
The Global Rhodiola Extract Market reached US$ 2.91 billion in 2023 and is expected to reach US$ 4.763 billion by 2031, growing with a CAGR of 6.30% during the forecast period 2024-2031.
The Rhodiola Extract Market is experiencing strong growth due to rising interest in adaptogenic herbs. Rhodiola rosea extract is known for reducing fatigue, stress, and improving cognitive performance. The global wellness movement and natural supplement trend drive its popularity.…
United States Familial Lipoprotein Lipase Deficiency Market Forecast: Gene Thera …
The Familial Lipoprotein Lipase Deficiency Market is valued at at a high CAGR during the forecast period (2024-2031).
This Familial Lipoprotein Lipase Deficiency market addresses a rare genetic disorder characterized by triglyceride metabolism impairment. Treatment focuses on dietary management, enzyme replacement, and novel gene therapy approaches. The market is driven by increasing awareness and precision diagnostics for rare diseases. Pharmaceutical R&D is intensifying to develop targeted enzyme-based therapeutics. Regulatory incentives and…
More Releases for Gabapentin
Unlocking Opportunities in the Gabapentin Market: 2025-2034 Forecast Report
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Gabapentin Industry Market Size Be by 2025?
In recent times, there's been significant growth in the size of the gabapentin market. It's projected to increase from $2.78 billion in 2024 to $3.01 billion in 2025, sporting a compound annual growth rate (CAGR) of 8.5%. Factors contributing…
Gabapentin Market to Grow with Leading Key Players
Global Gabapentin market reached at a Significant CAGR during the forecast period 2024-2031.
The Gabapentin market report provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Leveraging a combination of qualitative and quantitative research methods, the company offers comprehensive reports that help clients navigate complex…
Gabapentin Market size 2023, share, Demand and Outlook to 2032
"According to the research report, the global gabapentin market was valued at USD 1,981.60 million in 2022 and is expected to reach USD 3,036.38 million by 2032, to grow at a CAGR of 4.37% during the forecast period."
Polaris Market Research has recently published its latest analysis on Gabapentin Market 2023: By Types, Applications, Size, Share, Key Players & Regions Forecast Analysis till 2032. The study has been meticulously prepared to…
Growth Analysis & Projection of Gabapentin Market
The Gabapentin Market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. The report presents the overview of the market with the production of the cost, dispatch, application, use volume and…
Gabapentin Enacarbil Market Size, Share, Development by 2025
LP INFORMATION recently released a research report on the Acenocoumarol market analysis and elaborate the industry coverage, current market competitive status, and market outlook and forecast by 2025. Moreover, it categorizes the global Acenocoumarolmarket by key players, product type, applications and regions,etc.
The main objective of this market research is to help the readers understand the structure of Acenocoumarolmarket, market definition, overview, industry opportunities and trends, investment strategy with forceful…
Gabapentin Enacarbil Market: Competitive Dynamics & Global Outlook 2025
LP INFORMATION recently released a research report on the Gabapentin Enacarbil market analysis and elaborate the industry coverage, current market competitive status, and market outlook and forecast by 2025. Moreover, it categorizes the global Gabapentin Enacarbilmarket by key players, product type, applications and regions,etc.
The main objective of this market research is to help the readers understand the structure of Gabapentin Enacarbilmarket, market definition, overview, industry opportunities and trends, investment…
